Carfilzomib: no PFS benefit for multiple myeloma Presented ByProf. Shaji K. Kumar, Mayo Clinica, MN, USA TrialPhase 3, ENDURANCE (E1A11) ConferenceASCO 2020 28 August, 2020 16:00